Thermo Fisher Scientific Set to Acquire Qiagen for $11.5B

Thermo Fisher Scientific is set to acquire Qiagen in for $11.5 billion in a deal which is expected to be completed in the first half of 2021. The move comes about four months after rumors surfaced about the deal. The offer price represents a premium of about 23% to the closing price of Qiagen's common stock on the Frankfurt Prime Standard on March 2, 2020, the last trading day prior to the announcement of the transaction.